Topics

Companies Related to "Prostatic Artery Embolization Treat Complications" [Most Relevant Company Matches] RSS

07:24 EDT 1st April 2020 | BioPortfolio

Here are the most relevant search results for "Prostatic Artery Embolization Treat Complications" found in our extensive corporate database of over 50,000 company records.

Showing "Prostatic Artery Embolization Treat Complications" Companies 1–25 of 1,100+

Relevant

Embolx, Inc.

Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically improving the treatment of a variety of conditions including cancerous tumors, benign prostatic hyperplasia and uterine fibroids. The Sniper® balloon occlusion microcatheter sets a ...


Three Rivers Medical, Inc.

Three Rivers Medical, Inc. is a privately held medical device company focused on expanding the endovascular management of cerebral aneurysms and stroke. The company manufactures the Rio Embolization Coil System in Mountain View, CA. The Rio Embolization Coil System is not approved for sale in the United States.

Roche Biosciences

Today Roche Bioscience researchers are focused on the discovery and delivery of new medicines to treat the following diseases:Alzheimer's disease HIV/AIDS Arthritis Incontinence Asthma Osteoporosis Anxiety Overactive bladder Auto-immune disorders Benign prostatic hyperplasia Depression Pelvic hypersensitivity Emphysema and chronic bronchitis Schizophrenia Hepatitis C


Surgica Corporation

Surgica Corporation manufactures and markets embolization medical devices for the rapidly growing minimally invasive surgical and therapeutic specialties. Embolization is a minimally invasive procedure that can reduce tumors and vascular malformations by closing off the blood vessels that feed them.The procedure is performed by an interventional radiologist, who advances a catheter through the vas...

Lutonix, Inc.

Restenosis is the re-narrowing of an artery experienced by some patients following angioplasty, atherectomy, or stenting. Restenosis is caused by an overgrowth of tissue inside the artery wall at the original treatment site. Restenosis is typically experienced by some patients within the first 6 months of treatment, which most often results in re-intervention or surgery.

Pathway Medical Technologies Inc.

Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is on peripheral artery disease (PAD).According to the American Heart Association, peripheral artery disease affects 8 – 12 million in the U.S. PAD prevalence in...

BridgePoint Medical, Inc.

BridgePoint Medical, Inc. is a privately held company established in 2006 to design, develop and commercialize new technologies and techniques to treat challenging coronary artery disease. Investors include New Enterprise Associates, Polaris Venture Partners, Foundation Medical Partners and Michael Berman.

PROCEPT BioRobotics

Based in Silicon Valley, PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), the company’s first product, the AQUABEAM System delivering Aquablation therapy, is the world’s first commercially a...

Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally....

Healthy Life Screening

Located in Akron, Ohio, Healthy Life Screening was started in 2006 offering a range of preventive health screens on asymptomatic individuals for the presence of cardiovascular disease. The screening consists of five tests: left ventricle dysfunction, peripheral artery disease, abdominal aortic, carotid artery screening (including carotid intima-media thick...

ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of peripheral vascular and neurovascular diseases. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treat...

GTX

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel hormonal therapeutics for cancer and serious conditions related to men’s health. GTx's lead drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. GTx is developing...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment paradigm for treating peripheral ...

Intact Vascular, LLC

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Ohana Biosciences

At Ohana Biosciences, we are pioneering a reproductive health revolution through our industry-first platform of sperm-based technologies. We began with a vision to reimagine global reproductive health and help all people create the healthy family they dream of – when they are ready. Today, we believe our unprecedented understanding of sperm biology coupled with our pioneering research will t...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

AbbeyMoor Medical Incorporated

AbbeyMoor Medical, Inc. develops and manufactures devices for the management of urinary voiding dysfunction. AbbeyMoor’s first product The Spanner™ Temporary Prostatic Stent is designed to provide relief for men following a minimally invasive treatment for BPH.

Trimedyne

Trimedyne, Inc. is a manufacturer of lasers and disposable fiber optic delivery devices for use in a variety of surgical applications including, urology, orthopedics, ENT surgery, gynecology, GI surgery, and general surgery. Trimedyne's lasers and proprietary delivery systems are designed to reduce the bleeding and trauma of conventional surgery, reduce or eliminate hospital bed stays and shorten ...

Probably Relevant

Celsion

Founded in 1982, with a vision of using heat to kill cancer and treat other diseases, Celsion began trading publicly in 1985 under the name Cheung Laboratories, Inc. The early research focus of the Company was device oriented heat-based treatment systems. The Company was renamed Celsion Corporation and listed on the American Stock Exchange under the symbol CLN, in the mid 1990's. At that time, Cel...

Shape Memory Medical Inc.

Shape Memory Medical Inc., based in Santa Clara, California, is committed to developing multiple medical therapies with their novel Shape Memory Polymers for embolization. Visit www.shapemem.com.

PLC Systems

PLC is a global leader in the development of products for performing a revolutionary new surgical procedure known as transmyocardial revascularization (TMR). TMR offers a completely new medical treatment option for patients who suffer from severe coronary artery disease. Coronary artery disease is the leading cause of death in the United States. Working with leading researchers and premier heart...

Terumo Interventional Systems

Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Foxhollow Technologies

An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk® Plaque Excision System, a device that removes the plaque that commonly blocks arteries and interrupts blood flow. Unlike stenting and other methods of opening the artery, the SilverHawk removes the...


More From BioPortfolio on "Prostatic Artery Embolization Treat Complications"

Quick Search

Corporate Database Quicklinks